Page last updated: 2024-10-20

purine and Hepatocellular Carcinoma

purine has been researched along with Hepatocellular Carcinoma in 12 studies

1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.

Research Excerpts

ExcerptRelevanceReference
"Purine not only acts as a metabolic substrate of XOR for UA production, but it induces inflammation through IFN-γ secretion that stimulates UA production through elevation of XOR expression."4.12Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression. ( Huang, D; Li, X; Liang, B; Lin, Z; Song, X; Su, T; Wang, H; Wang, J; Xie, L, 2022)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's1 (8.33)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Wang, H1
Xie, L1
Song, X1
Wang, J1
Li, X1
Lin, Z1
Su, T1
Liang, B1
Huang, D1
Zhao, JZ2
Wang, W2
Liu, T2
Zhang, L2
Lin, DZ2
Yao, JY2
Peng, X2
Jin, G2
Ma, TT2
Gao, JB2
Huang, F2
Nie, J2
Lv, Q2
Hung, MH1
Chang, CW1
Wang, KC1
Chaisaingmongkol, J1
Ruchirawat, M1
Greten, TF1
Wang, XW1
Ma, F1
Zhu, Y1
Liu, X1
Zhou, Q1
Hong, X1
Qu, C1
Feng, X1
Zhang, Y1
Ding, Q1
Zhao, J1
Hou, J1
Zhong, M1
Zhuo, H1
Zhong, L1
Ye, Z1
Xie, W1
Liu, Y1
Xiong, Y1
Chen, H1
Piao, D1
Sun, B1
Gao, Z1
Li, Q1
Zhang, Z2
Qiu, X1
WERKHEISER, WC1
WINZLER, RJ1
VISSER, DW1
DE LAMIRANDE, G1
ALLARD, C1
CANTERO, A1
SARTORELLI, AC2
BOOTH, BA2
WHEELER, GP1
ALEXANDER, JA1
DODSON, AS1
BRIGGS, SD1
MORRIS, HP1
LARSSON, A1
POTTER, VR1
Arranz, N1
Haza, AI1
García, A1
Delgado, E1
Rafter, J1
Morales, P1

Other Studies

12 other studies available for purine and Hepatocellular Carcinoma

ArticleYear
Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Hepatocytes; Humans; Inflammation; Interferon-gamma; Ju

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells.
    BMC cancer, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progre

2022
Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.
    Hepatology (Baltimore, Md.), 2023, 11-01, Volume: 78, Issue:5

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; DNA Repair; Epigenesis, Genetic; Gene Expre

2023
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Loss Activates Purine Metabolism and Promotes Hepatocellular Carcinoma Progression.
    Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:5

    Topics: Activating Transcription Factor 4; Carcinoma, Hepatocellular; Disease Progression; Humans; Liver Neo

2019
Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices.
    Cancer research, 1955, Volume: 15, Issue:10

    Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Nucleic Acids; Nucleotides; P

1955
Purine-metabolizing enzymes in normal rat liver and Novikoff hepatoma.
    Cancer research, 1958, Volume: 18, Issue:8 Part 1

    Topics: Animals; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Metabolic

1958
Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    Biochemical pharmacology, 1960, Volume: 5

    Topics: Animals; Antineoplastic Agents; Azaserine; Carcinoma, Hepatocellular; Liver Neoplasms; Neoplasms; Pu

1960
Searches for exploitable biochemical differences between normal and cancer cells. IX. Anabolism and catabolism of purines by hepatomas 5123 and H-35.
    Cancer research, 1962, Volume: 22

    Topics: Animals; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Purines

1962
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    Cancer research, 1963, Volume: 23

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor;

1963
ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES. III. REDUCTION OF PURINE RIBONUCLEOTIDES WITH AN ENZYME SYSTEM FROM ESCHERICHIA COLI B.
    The Journal of biological chemistry, 1963, Volume: 238

    Topics: Adenine Nucleotides; Carcinoma, Hepatocellular; Deoxyribonucleotides; Escherichia coli; Guanine Nucl

1963
NEW PROSPECTS IN CANCER BIOCHEMISTRY.
    Advances in enzyme regulation, 1963, Volume: 1

    Topics: Antineoplastic Agents; Carbohydrate Metabolism; Carcinoma, Hepatocellular; Feedback; Glucose; Glucos

1963
Effects of organosulfurs, isothiocyanates and vitamin C towards hydrogen peroxide-induced oxidative DNA damage (strand breaks and oxidized purines/pyrimidines) in human hepatoma cells.
    Chemico-biological interactions, 2007, Aug-15, Volume: 169, Issue:1

    Topics: Ascorbic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Comet Assay; Cytoprotection; DNA Damage;

2007